544205 — National Peroxide Cashflow Statement
0.000.00%
- IN₹2.87bn
- IN₹2.40bn
- IN₹2.87bn
- 41
- 43
- 25
- 25
Annual cashflow statement for National Peroxide, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 535 | 215 | -20.8 |
| Depreciation | |||
| Non-Cash Items | 32 | -13.2 | -14.1 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -93.9 | -30.5 | 20.5 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 671 | 364 | 187 |
| Capital Expenditures | -59.9 | -146 | -48.9 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 308 | -28.8 | 31.6 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 248 | -175 | -17.3 |
| Financing Cash Flow Items | -63 | -27.1 | -15.9 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -860 | -167 | -125 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 59.3 | 21.8 | 43.2 |